Navidea Biopharmaceuticals, Inc. NAVBQ
OTC PK
| 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | 06/30/2022 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 18,077.22% | -98.31% | -56.62% | 1,302.68% | -73.05% |
| Total Receivables | 44.19% | 5,066.67% | -99.61% | 415.61% | -74.01% |
| Inventory | 0.02% | 7.79% | 120.49% | -38.61% | -2.26% |
| Prepaid Expenses | -47.15% | -13.84% | 419.72% | -69.80% | -25.53% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 484.93% | -62.62% | -37.18% | 335.63% | -49.61% |
|
|
|||||
| Total Current Assets | 484.93% | -62.62% | -37.18% | 335.63% | -49.61% |
| Net Property, Plant & Equipment | -3.86% | -5.08% | -16.12% | -13.80% | -13.85% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 5.04% | 1.04% | 6.27% | 5.68% | 11.09% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.00% | 0.00% | -62.89% | -86.00% | 0.00% |
| Total Assets | 247.18% | -45.84% | -30.15% | 149.97% | -30.49% |
|
|
|||||
| Total Accounts Payable | -36.68% | 49.40% | 22.09% | -28.36% | 55.07% |
| Total Accrued Expenses | -13.79% | -33.13% | 27.34% | 195.45% | -17.29% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 278.64% | -37.18% | 1,960.81% | -76.94% | -62.06% |
| Total Finance Division Other Current Liabilities | -12.09% | 75.79% | -49.83% | 50.56% | 11.85% |
| Total Other Current Liabilities | -12.09% | 75.79% | -49.83% | 50.56% | 11.85% |
| Total Current Liabilities | -10.21% | -6.96% | 17.89% | 58.45% | 8.61% |
|
|
|||||
| Total Current Liabilities | -10.21% | -6.96% | 17.89% | 58.45% | 8.61% |
| Long-Term Debt | -- | 4.93% | 4.51% | 148.65% | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -44.44% | -30.77% | -23.53% | -19.05% | -81.42% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 0.00% | 0.00% | 0.00% | 0.00% | -12.50% |
| Total Liabilities | -24.41% | -4.79% | 14.55% | 61.99% | 18.08% |
|
|
|||||
| Common Stock & APIC | 0.77% | 0.02% | 0.00% | 1.97% | 0.23% |
| Retained Earnings | 1.50% | -0.38% | -0.91% | -2.06% | -0.80% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 89.03% | -16.65% | -70.09% | -9.41% | -88.73% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -100.00% |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -100.00% |
|
|
|||||
| Total Common Equity | 89.03% | -16.65% | -70.09% | -9.41% | -88.73% |
| Total Preferred Equity | -- | -- | -- | -- | -100.00% |
| Total Minority Interest | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Equity | 91.76% | -17.24% | -74.48% | -10.06% | -101.03% |
|
|
|||||